PRAME and cancer: Upon mapping the list of peptides to genes and referencing those genes for tissue expression levels, we observed several known cancer targets with favorable therapeutic windows, including PHOX2B (8), PRAME (48), and SOX11, a primarily developmental transcription factor expressed in many different tumors (Fig. 8D) (49).